|
1
|
Compare D, Rocco A and Nardone G: Risk
factors in gastric cancer. Eur Rev Med Pharmacol Sci. 14:302–308.
2010.
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
3
|
Petrocca F, Visone R, Onelli MR, Shah MH,
Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini
M, et al: E2F1-regulated microRNAs impair TGFbeta-dependent
cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell.
13:272–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lau NC, Lim LP, Weinstein EG and Bartel
DP: An abundant class of tiny RNAs with probable regulatory roles
in Caenorhabditis elegans. Science. 294:858–862. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee RC and Ambros V: An extensive class of
small RNAs in Caenorhabditis elegans. Science. 294:862–864.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bueno MJ, Pérez de Castro I and Malumbres
M: Control of cell proliferation pathways by microRNAs. Cell Cycle.
7:3143–3148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lauren P: The two histological main types
of gastric carcinoma: diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.
|
|
11
|
Tamura G, Yin J, Wang S, Fleisher AS, Zou
T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, et al:
E-Cadherin gene promoter hypermethylation in primary human gastric
carcinomas. J Natl Cancer Inst. 92:569–573. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuasa Y: Control of gut differentiation
and intestinal-type gastric carcinogenesis. Nat Rev Cancer.
3:592–600. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bonhomme C, Duluc I, Martin E,
Chawengsaksophak K, Chenard MP, Kedinger M, Beck F, Freund JN and
Domon-Dell C: The Cdx2 homeobox gene has a tumour suppressor
function in the distal colon in addition to a homeotic role during
gut development. Gut. 52:1465–1471. 2003. View Article : Google Scholar
|
|
14
|
Bai YQ, Yamamoto H, Akiyama Y, Tanaka H,
Takizawa T, Koike M, Kenji Yagi O, Saitoh K, Takeshita K, Iwai T
and Yuasa Y: Ectopic expression of homeodomain protein CDX2 in
intestinal metaplasia and carcinomas of the stomach. Cancer Lett.
176:47–55. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eda A, Osawa H, Yanaka I, Satoh K, Mutoh
H, Kihira K and Sugano K: Expression of homeobox gene CDX2 precedes
that of CDX1 during the progression of intestinal metaplasia. J
Gastroenterol. 37:94–100. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mutoh H, Sakurai S, Satoh K, Tamada K,
Kita H, Osawa H, Tomiyama T, Sato Y, Yamamoto H, Isoda N, et al:
Development of gastric carcinoma from intestinal metaplasia in
Cdx2-transgenic mice. Cancer Res. 64:7740–7747. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mao ZB, Zhang JF, Xu Z, Zhu HJ, Zhang JG,
Pan ZP, Xiao F and Yang JL: Ectopic expression of guanylyl cyclase
C in gastric cancer as a potential biomarker and therapeutic
target. J Dig Dis. 10:272–285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang JF, Zhang JG, Kuai XL, Zhang H,
Jiang W, Ding WF, Li ZL, Zhu HJ and Mao ZB: Reactivation of the
homeotic tumor suppressor gene CDX2 by
5-aza-2′-deoxycytidine-induced demethylation inhibits cell
proliferation and induces caspase-independent apoptosis in gastric
cancer cells. Exp Ther Med. 5:735–741. 2013.PubMed/NCBI
|
|
19
|
Qin R, Wang NN, Chu J and Wang X:
Expression and significance of homeodomain protein Cdx2 in gastric
carcinoma and precancerous lesions. World J Gastroenterol.
18:3296–3302. 2012.PubMed/NCBI
|
|
20
|
Xie Y, Li L, Wang X, Qin Y, Qian Q, Yuan X
and Xiao Q: Overexpression of Cdx2 inhibits progression of gastric
cancer in vitro. Int J Oncol. 36:509–516. 2010.PubMed/NCBI
|
|
21
|
Barros R, Camilo V, Pereira B, Freund JN,
David L and Almeida R: Pathophysiology of intestinal metaplasia of
the stomach: emphasis on CDX2 regulation. Biochem Soc Trans.
38:358–363. 2010. View Article : Google Scholar : PubMed/NCBI
|
